206. Fragile X syndrome Clinical trials / Disease details
Clinical trials : 108 / Drugs : 91 - (DrugBank : 36) / Drug target genes : 52 - Drug target pathways : 77
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT02719951 (ClinicalTrials.gov) | April 2016 | 9/3/2016 | Glutaminergic Transmission in Autism : Molecular Imaging Exploration | Glutaminergic Transmission in Autism : Molecular Imaging Exploration | Autism;Fragile-X Syndrome (FXS);Healthy Volunteers | Drug: [18F]FPEB PET imaging;Other: Biological samples;Other: MRI | University Hospital, Tours | NULL | Completed | 18 Years | 45 Years | Male | 27 | Phase 1 | France |